Is IUSG a Good Investment? The Case For and Against (2026)
Last updated September 2026
Short answer
The case for IUSG is simple: low-cost, diversified exposure to the S&P U.S. Growth Index at a 0.04% expense ratio, anchored by names like NVDA, MSFT, AAPL. If that is the exposure you want and you do not already own most of it through another fund, IUSG is a strong core holding. The catch is concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want the S&P U.S. Growth Index and at what cost. Not a recommendation; Walnut is not an investment adviser.
What are you buying with IUSG?
IUSG holds US large-cap growth companies screened by S&P, and its portfolio is close to indistinguishable from the other large growth funds: Nvidia at 13.0%, Microsoft at 7.4%, Apple at 5.7%, Alphabet at 5.6% and 4.5% across share classes, and Broadcom at 4.8%. What sets it apart is the fee. At 0.04% it is roughly a quarter of what IVW charges for materially the same exposure, which makes it the cheapest mainstream way to express this particular tilt.
Largest holdings (approximate as of August 2026; verify on iShares's fund page):
What's the case for IUSG?
The same mega-cap growth trade as IVW, at 0.04% instead of 0.18%.
In its favour: it gives you the S&P U.S. Growth Index exposure in one ticker at a 0.04% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying IUSG?
- Cost vs alternatives: 0.04% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of IUSG sits in its largest holdings (NVDA, MSFT, AAPL).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: IUSG only gives you the S&P U.S. Growth Index; it will not capture what sits outside that index.
How concentrated is IUSG?
“Diversified” is the word every index fund uses and it hides a wide range. The number that actually matters is how much of the fund sits in its largest positions, because that is the part that drives the return. In IUSG, the three largest positions are about 26.1% of the fund and the 10 largest are about 53.6%, with the single biggest at roughly 13%. Those are approximate weights as of August 2026, and because this is the published top 10 rather than the full book, treat 53.6% as a floor on concentration rather than the whole picture. Verify with iShares.
That is a moderately concentrated fund. The largest names matter to the outcome without dominating it, which is typical of a broad market-cap-weighted index and is the shape most core holdings have.
This is also the number that decides whether IUSG adds diversification to your portfolio rather than to a portfolio in the abstract. A fund can be well spread on its own and still concentrate you further, if its largest holdings are names you already own directly or through another fund. That is a question about your account rather than about IUSG, and it is the one worth answering before you buy.
What IUSG does not give you
A fund is defined as much by what it leaves out as by what it holds, and the exclusions are rarely on the marketing page. IUSG tracks the S&P U.S. Growth Index, so anything outside that index is simply absent from your portfolio no matter how much of the fund you own.
In practice that means checking three gaps. Whether the geography you want is covered, since a US index holds no international companies and a developed-markets index holds no emerging ones. Whether the size band you want is covered, because a large-cap index excludes the smaller companies some investors specifically want exposure to. And whether the asset class you want is covered at all, since an equity fund holds no bonds and gives you nothing to rebalance against in a drawdown.
None of these are faults. They are the fund doing exactly what it says. The mistake is assuming that owning a diversified fund means being diversified, when it means being diversified within one index.
When IUSG is the wrong choice
Being specific about this is more useful than another paragraph on why it might be right.
- You already own most of it. If a broad-market fund you hold already contains NVDA, MSFT, AAPL at meaningful weight, adding IUSG mostly increases your exposure to the same companies while adding a second fee. That is the single most common way people accidentally concentrate.
- You want the exposure for a short horizon. An index fund is a way to own an asset class over years. Over months it is simply the index, with all of the index's volatility and none of the compounding that makes holding it worthwhile.
- You need income you can rely on. Distributions from an equity index fund vary with what the underlying companies pay, so they are not a schedule you can plan around the way a bond ladder is.
- A cheaper fund tracks the same thing. Where two funds follow a similar index, the difference in expense ratio is one of the few advantages available to you without taking extra risk. Compare before assuming 0.04% is competitive.
How do you decide if IUSG is a buy?
The useful question is rarely “will IUSG go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how IUSG would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on IUSG
The bottom line: IUSG is a low-cost core building block for the S&P U.S. Growth Index exposure, not a tactical bet on a single name. If you want the S&P U.S. Growth Index exposure and the 0.04% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
More on IUSG
- What is IUSG? (holdings, cost, performance, and the themes it covers)
- IUSG dividend: yield and schedule
Investing in IUSG with AI
Connect the broker you already use and ask Walnut's AI how IUSG fits what you actually hold: what it overlaps with, what it leaves you exposed to, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is IUSG a good ETF to buy?
+
Walnut is informational, not investment advice. Whether IUSG fits depends on your goals, time horizon, and what you already hold. It tracks the S&P U.S. Growth Index at a 0.04% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does IUSG actually hold?
+
IUSG tracks the S&P U.S. Growth Index. Its largest positions include NVDA, MSFT, AAPL, GOOGL, AVGO and others (approximate, verify on iShares's fund page). The holdings are what you are really buying, not the ticker.
What is IUSG's expense ratio?
+
0.04% as of August 2026. Over decades, the expense ratio is one of the few things you can control, so it is worth comparing against close alternatives that track a similar index.
Does IUSG pay a dividend?
+
IUSG distributes a dividend with an approximate yield of 0.49% (August 2026). See the IUSG dividend page for how distributions work. Verify the current figure with iShares.
What are the risks of buying IUSG?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether the S&P U.S. Growth Index matches the exposure you actually want. IUSG only gives you the S&P U.S. Growth Index, not what sits outside it.
How do I decide if IUSG is right for me?
+
Start from your goal, then check four things: what IUSG holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to August 2026; verify current data with iShares or your broker. Nothing here is a recommendation to buy, sell, or hold any security.